Smith Group Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Smith Group Asset Management, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $173.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$173.2M
| Company | Shares | Value |
|---|---|---|
| MCKMcKesson Corporation | 62,597 | $54.2M |
| MEDPMedpace Holdings Inc. | 103,603 | $49.7M |
| JNJJOHNSON & JOHNSON | 150,121 | $36.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 55,746 | $24.9M |
| LLYELI LILLY & Co | 2,117 | $1.9M |
| PAHCPHIBRO ANIMAL HEALTH CORP | 25,021 | $1.4M |
| BMYBRISTOL MYERS SQUIBB CO | 13,850 | $840K |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | 21,951 | $726K |
| ABBVAbbVie Inc. | 3,169 | $689K |
| CAHCardinal Health Inc. | 3,018 | $638K |
| MMSIMerit Medical Systems Inc. | 6,415 | $442K |
| IDXXIDEXX LABORATORIES INC /DE | 661 | $371K |
| DVADaVita Inc. | 2,355 | $362K |
| HALOHALOZYME THERAPEUTICS, INC. | 4,930 | $319K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.